Abstract: The present disclosure relates to methods of treating neurological diseases, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein. The present disclosure relates to the methods of treating Parkinson's disease and Dementia with Lew Bodies, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.

Abstract: The present disclosure relates to methods of treating dry age-related macular degeneration (dry AMD), comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.

Abstract: This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.

Abstract: This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.

Abstract: This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.

Abstract: This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.

Abstract: A vertical planting tray comprising a plurality of substantially horizontal shelves held together by outer side walls and a plurality of vertical struts located therebetween with the struts connected to and supporting the shelves, the struts being substantially thin and narrow an defining a plurality of planting stations with the horizontal shelves in which vertical plants may be grown. The substantial open wall structure between stations permits improved plant performance.

Abstract: A vertical planting tray comprising a plurality of substantially horizontal shelves held together by outer side walls and a plurality of vertical struts located therebetween with the struts connected to and supporting said shelves, said struts being substantially thin and narrow and defining a plurality of planting stations with said horizontal shelves in which vertical plants may be grown. The substantial open wall structure between stations permits improved plant performance.

Abstract: Disclosed herein is the use of aminopyridines, such as 3-aminopyridine, 4-aminopyridine or 3,4-diaminopyridine, in the management and treatment of cerebral palsy patients of all ages.

Abstract: This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury.

Abstract: The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.

Abstract: The present invention is directed to a method of improving functional recovery following a central nervous system contusion injury. The method includes administering a therapeutically effective amount of glycosaminoglycan degrading enzyme. The glycosaminoglycan degrading enzyme may be dermatan sulfate or chondroitin sulfate degrading enzymes. The central nervous system contusion injury may include a traumatic brain injury or a spinal cord injury. The functional recovery may include autonomic functions, sensory functions, motor functions or the like.

Abstract: One aspect of the present invention relates to mutants of chondroitinase ABCI. Such chondroitinase ABCI mutants exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to UV light or heat. Methods of using chondroitinase ABCI mutant enzymes are also provided.

Abstract: The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and their use for neurological functional recovery after central nervous system (“CNS”) injury or disease.

Abstract: A method and system is disclosed for procuring real estate agreements, including future real estate agreements. The present method and system provide individuals with a financial incentive that is transferred to a third party, such as a charity, non-profit organization (e.g., a university, college, other academic institution, religious institution, or the like) or other fundraising entity (e.g., a political party, action committee, candidate or the like), in exchange for entering into future real estate agreements. The individuals may include present and future homeowners who may or may not be presently engaged in a real estate transaction.